|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/402 | |
| A61K 31/4164 | |||
| A61K 31/437 | |||
| A61K 45/06 | |||
| A61P 35/00 |
| (11) | Number of the document | 2827859 |
| (13) | Kind of document | T |
| (96) | European patent application number | 13709468.6 |
| Date of filing the European patent application | 2013-03-18 | |
| (97) | Date of publication of the European application | 2015-01-28 |
| (45) | Date of publication and mention of the grant of the patent | 2018-10-17 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/EP2013/055522 |
| Date | 2013-03-18 |
| (87) | Number | WO 2013/139724 |
| Date | 2013-09-26 |
| (30) | Number | Date | Country code |
| 201261612441 P | 2012-03-19 | US |
| (72) |
HIGGINS, Brian, US
KOLINSKY, Kenneth, US
NICHOLS, Gwen, US
PACKMAN, Kathryn E., US
SU, Fei, US
|
| (73) |
F. Hoffmann-La Roche AG,
Grenzacherstrasse 124, 4070 Basel,
CH
|
| (54) | COMBINATION THERAPY (VEMRUFENIB AND A MDM2 INHIBITOR) FOR THE TREATMENT PROLIFERATIVE DISORDERS |
| COMBINATION THERAPY (VEMRUFENIB AND A MDM2 INHIBITOR) FOR THE TREATMENT PROLIFERATIVE DISORDERS |